Literature DB >> 36169882

Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis.

Fariba Aghaei1, Ehsan Arabzadeh2, Hamideh Mahmoodzadeh Hosseini3, Hossein Shirvani4.   

Abstract

Lifestyle modification with regular exercise can improve metabolic diseases by reducing lipid profile and inflammation. Probiotics have been recently recommended not only for gastrointestinal diseases but also for metabolic and even degenerative diseases. Therefore, in the present study, the effect of high-intensity interval training (HIIT) and Lacticaseibacillus rhamnosus strain GG (LGG) as a probiotic on tetracycline-induced hepatic steatosis in an animal model was evaluated. Eighty male Wistar rats were randomly divided into eight groups (n = 10 in each group): control, LGG, HIIT, LGG + HIIT, tetracycline-induced (TTC), TTC + LGG, TTC + HIIT, and TTC + LGG + HIIT. The rats are treated by intraperitoneal injection (IP) with 140 mg kg-1 tetracycline, an antibiotic previously known to induce steatosis. The exercise training groups performed HIIT 5 days/week for 5 weeks, and 107 CFU/ml of Lacticaseibacillus rhamnosus GG was gavaged for the LGG groups 5 days/week for 5 weeks. Fatty droplets in the hepatocyte were considered with Oil Red staining. TTC-receiving rats have more lipid accumulation and larger lipid droplets in the liver compared to healthy animals. The two-way ANOVA showed that the interaction of LGG and HIIT significantly decreased LDL, cholesterol, and triglyceride in the healthy rats (p < 0.05). In TTC-receiving rats, the interaction of LGG and HIIT significantly increased HDL and SOD and significantly decreased triglyceride, ALP, AST, and ALT (p < 0.05). The consumption of probiotic LGG, along with HIIT with control of lipid profile and liver enzymes and improvement of the oxidative capacity, neutralizes the damage of TTC to liver tissue. Therefore, this protocol can be recommended for people with hepatic steatosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Exercise training; Hepatic steatosis; Lipid profile; Oxidative capacity; Probiotics

Year:  2022        PMID: 36169882     DOI: 10.1007/s12602-022-09994-6

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   5.265


  39 in total

Review 1.  Foods and liver health.

Authors:  Filomena Morisco; Paola Vitaglione; Daniela Amoruso; Barbara Russo; Vincenzo Fogliano; Nicola Caporaso
Journal:  Mol Aspects Med       Date:  2007-10-07

Review 2.  NAFLD: a multisystem disease.

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

3.  Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.

Authors:  Peng Chen; Peter Stärkel; Jerrold R Turner; Samuel B Ho; Bernd Schnabl
Journal:  Hepatology       Date:  2015-01-30       Impact factor: 17.425

Review 4.  Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.

Authors:  Sara Ceccarelli; Valerio Nobili; Anna Alisi
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.

Authors:  Forouzan Faghihzadeh; Peyman Adibi; Rahmatollah Rafiei; Azita Hekmatdoost
Journal:  Nutr Res       Date:  2014-09-23       Impact factor: 3.315

Review 6.  Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?

Authors:  Y Yilmaz
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

7.  Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease.

Authors:  Tania Roskams; Shi Qi Yang; Aymen Koteish; Anne Durnez; Rita DeVos; Xiawen Huang; Ruth Achten; Chris Verslype; Anna Mae Diehl
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.

Authors:  Samaneh Hosseinabadi; Maryam Rafraf; Somayyeh Asghari; Mohammad Asghari-Jafarabadi; Shohreh Vojouhi
Journal:  Complement Ther Med       Date:  2019-12-26       Impact factor: 2.446

9.  Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.

Authors:  Vanessa Bullón-Vela; Itziar Abete; Josep A Tur; Xavier Pintó; Emili Corbella; Miguel A Martínez-González; Estefanía Toledo; Dolores Corella; Manuel Macías; Francisco Tinahones; Montserrat Fitó; Ramon Estruch; Emilio Ros; Jordi Salas-Salvadó; Lidia Daimiel; M Angeles Zulet; J Alfredo Martínez
Journal:  Nutrition       Date:  2019-10-25       Impact factor: 4.008

Review 10.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Elena Buzzetti; Massimo Pinzani; Emmanuel A Tsochatzis
Journal:  Metabolism       Date:  2016-01-04       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.